Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients with Newly Diagnosed Type 2 Diabetes

机译：超重/肥胖新诊断2型糖尿病患者中艾塞那肽和二甲双胍单药治疗的比较

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aims The present study assessed the therapeutic effect of exenatide and metformin as the initial therapy on overweight/obese patients with newly diagnosed type 2 diabetes (T2D).

机译：目的本研究评估了艾塞那肽和二甲双胍作为新诊断为2型糖尿病（T2D）的超重/肥胖患者的初始治疗的疗效。

著录项

期刊名称 International Journal of Endocrinology
作者
Jia Liu; Yanjin Hu; Yuan Xu; Yumei Jia; Li Miao; Guang Wang;
展开▼
作者单位

展开▼
年(卷),期 2017(2017),-1
年度 2017
页码 9401606
总页数 6
原文格式 PDF
正文语种
中图分类基础医学;
关键词

相似文献

外文文献
中文文献
专利

1. Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients with Newly Diagnosed Type 2 Diabetes [J] . Liu Jia, Hu Yanjin, Xu Yuan, International journal of endocrinology . 2017,第Pta2期

机译：Exenatide和二甲双胍单疗法对新诊断的2型糖尿病患者超重/肥胖患者的比较
2. Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients with Newly Diagnosed Type 2 Diabetes [J] . Jia Liu, Yanjin Hu, Yuan Xu, International journal of endocrinology . 2017,第Pta1期

机译：Exenatide和二甲双胍单疗法对新诊断的2型糖尿病患者超重/肥胖患者的比较
3. Efficacy and tolerability of exenatide monotherapy in obese patients with newly diagnosed type 2 diabetes: a randomized, 26weeks metformin-controlled, parallel-group study [J] . YUAN Ge-heng, SONG Wei-li, HUANG You-yuan, 中华医学杂志（英文版） . 2012,第015期

机译：艾塞那肽单药治疗肥胖的新诊断2型糖尿病患者的疗效和耐受性：一项随机，26周，以二甲双胍为对照的平行组研究
4. Choice-Based User Interface Design of a Smart Healthy Food Recommender System for Nudging Eating Behavior of Older Adult Patients with Newly Diagnosed Type Ⅱ Diabetes [C] . Wen-Yu Chao, Zachary Hass International Conference on Human Aspects of IT for the Aged Population;International Conference on Human-Computer Interaction . 2020

机译：一种基于智能的健康食品推荐系统的基于选择的用户界面设计，该系统可以对新诊断的Ⅱ型糖尿病的老年患者的饮食行为进行判断。
5. Comparison of monotherapy with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in improving health outcomes among veteran patients with type 2 diabetes. [D] . Campbell, Heather M. 2011

机译：与血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂单一疗法改善2型糖尿病退伍军人患者健康结局的比较。
6. A crossover study of the combination therapy of metformin and exenatide or biphasic insulin aspart 30 in overweight or obese patients newly diagnosed with type 2 diabetes mellitus [O] . Huibiao Quan, Huachuan Zhang, Weiping Wei, -1

机译：二甲双胍与艾塞那肽或天冬氨酸双相胰岛素30联合治疗在新诊断为2型糖尿病的超重或肥胖患者中的交叉研究
7. A crossover study of the combination therapy of metformin and exenatide or biphasic insulin aspart 30 in overweight or obese patients newly diagnosed with type 2 diabetes mellitus [O] . Huibiao Quan, Huachuan Zhang, Weiping Wei, 2017

机译：二甲双胍和艾塞那肽组合治疗或双相胰岛素Aspart 30的交叉研究，超重或肥胖患者新诊断为2型糖尿病

Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients with Newly Diagnosed Type 2 Diabetes

摘要

著录项

相似文献

相关主题

期刊订阅